‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit
admin The biopharmaceutical sector witnessed a dynamic period marked by significant clinical advancements, strategic corporate maneuvers,...
biotech
Cancer Research Institute Bolsters Immunotherapy Frontier with $2.5 Million Boost for Next-Generation Postdoctoral Fellows
The Cancer Research Institute (CRI) has announced its Fall 2025 and Spring 2026 classes of...
Latigo Biotherapeutics Secures $345.6 Million in Landmark IPO, Poised to Challenge Giants in Non-Opioid Pain Market Amidst Biotech Resurgence
Pain drugmaker Latigo Biotherapeutics successfully completed its initial public offering (IPO) on Thursday, August 7,...
Dr. Erica Schwartz Confirmed as CDC Director Amidst Deep-Seated Challenges and Public Health Turmoil
Dr. Erica Schwartz has been confirmed as the next director of the Centers for Disease...
Paving the Path to a Cancer-Free Future: The Enduring Impact of Legacy Giving to the Cancer Research Institute
Including the Cancer Research Institute (CRI) in your will is a personal and meaningful way...
Tarsus Pharmaceuticals Acquires Alkeus Pharmaceuticals in Up to $800 Million Deal, Advancing Stargardt Disease Treatment
Tarsus Pharmaceuticals, a prominent developer of treatments across ophthalmology, dermatology, and infectious diseases, has announced...
July: A Critical Call for UV Radiation Safety and Advances in Skin Cancer Immunotherapy
As July unfolds, marking Ultraviolet (UV) Radiation Safety Awareness Month, a renewed focus is cast...
FDA Grants Accelerated Approval to Replimune’s Tudriqev for Advanced Melanoma After Contentious Review Process
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Replimune’s novel...
The Evolving Landscape of Sarcoma Treatment: Immunotherapy Offers New Hope Amidst Complexity
Sarcoma, a rare and notably complex group of cancers, presents unique challenges for diagnosis and...
FDA Approves Orzeyful, a Groundbreaking Orexin-2 Agonist, Ushering in a New Era for Narcolepsy Type 1 Treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Orzeyful, a novel medicine...
